Athira Pharma, Inc.ATHANASDAQ
LOADING
|||
R&D Expense Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
-24.64%
↓ 131% below average
Average (6y)
78.52%
Historical baseline
Range
High:250.28%
Low:-24.64%
Volatility
350.1%
High variability
| Period | Value |
|---|---|
| 2024 | -24.64% |
| 2023 | 52.59% |
| 2022 | 43.63% |
| 2021 | 222.10% |
| 2020 | 250.28% |
| 2019 | 5.68% |
| 2018 | 0.00% |